Ingredion Incorporated Reports Third Quarter 2026 Results

Ingredion Incorporated (INGR) reported Q3 2026 results with net sales volume growth in T&HS but a 19% decrease in operating income. Diluted EPS was $2.23 (reported) and $2.28 (adjusted), down from $2.61 and $2.75 in Q3 2025. The company lowered full-year EPS guidance due to higher input costs and softer demand. CEO Jim Zallie cited Argo's slower recovery and manufacturing cost pressures as key challenges.

Original reporting
Published Nov 5, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 12:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$INGR
Bearish
high confidence
Mentioned
$INGR
Relevance
7/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$INGRBearishMed
01

Why it matters

The earnings miss and lowered guidance are likely to trigger a sell‑off, but long‑term growth platforms and the Tate & Lyle deal may provide upside.

02

Market read

First‑report earnings with guidance downgrade for a mid‑cap ingredient company; relevant for traders in consumer‑staples and specialty chemicals.

03

What to watch

Potential upside from the pending Tate & Lyle acquisition and continued clean‑label demand.

Relevance 7/10Novelty 8/10Timing: today

Background

Ingredion reported its Q3 2026 earnings, noting slower recovery at its Argo plant, higher input costs, and a sale of its Pakistan business.

Company-level read

Ticker impact

$INGRBearishHigh confidence
Context

Q3 2026 results posted with EPS down 19% YoY and full-year EPS guidance lowered.

Expected impact

likely pressure as the market prices in weaker earnings and lower outlook

Evidence & confidence

Both reported EPS and guidance are new, material numbers for a mid‑cap issuer.

Market effects

Ingredient solutions sector may see broader pressure as peers face similar input‑cost challenges.

North American food‑ingredient manufacturers could see margin compression.

Limited to companies with exposure to clean‑label trends and commodity cost inflation.

Counterpoint

If cost‑saving initiatives succeed, the stock could rebound despite the guidance cut.

Key entities

  • Ingredion Incorporated

    Global provider of ingredient solutions, ticker INGR.

Related articles

$INGRMed

What Ingredion (INGR) Said on Its Q3 Earnings Call

Ingredion (INGR) reported Q3 earnings with mixed results. Texture & Healthful Solutions saw 2% volume growth but a 10% drop in operating income due to higher tapioca costs. Latin America segment faced currency impacts and earthquake disruptions. The company expects flat to low-single-digit operating income growth for the year and is progressing with its Tate & Lyle acquisition.

$INGRMed

Ingredion 3Q 2026: Revenue $1.79B, EPS $2.23 — 10-Q Summary

Ingredion reported 3Q 2026 revenue of $1.79B, down 1.3% YoY, and EPS of $2.23, down 14.6%. Net income fell 17% to $142M. Declines were attributed to lower gross profit, acquisition costs, and higher manufacturing expenses, partly offset by foreign exchange gains and higher volumes. Sales in most segments were impacted by various factors, including currency impacts and natural disasters.

$INGRMed

Ingredion (INGR) Q3 2026 Earnings Call Transcript

Ingredion (INGR) reported Q3 2026 earnings below expectations, with net sales up 2% excluding the Pakistan business sale. Higher manufacturing costs and a stronger Mexican peso pressured profitability. The company lowered its full-year outlook due to slower-than-expected profit recovery at Argo and cautious consumer demand views. Texture & Healthful Solutions saw 2% net sales volume growth, while Food & Industrial Ingredients LATAM grew 4%.

$INGRHighAI 8/10

Ingredion Q3 2026: Adjusted EPS Falls to $2.28 as Operating Income Drops 19%

Ingredion reported Q3 2026 net sales of $1.79B, down 1% YoY, with operating income falling 19% to $201M. Adjusted EPS dropped to $2.28 from $2.75. The company revised its full-year adjusted EPS guidance to $9.25–$9.70. Sales volume grew in Texture & Healthful Solutions, while Food & Industrial Ingredients faced challenges. Ingredion is integrating its Tate & Lyle acquisition and focusing on cost management.